House Ways and Means Committee leaders today released a white paper summarizing stakeholder recommendations for Medicare-related legislation to address the opioid crisis, which the committee plans to use to develop and advance bipartisan policies. The committee in February requested feedback on specific questions related to overprescribing, data tracking, beneficiary notification, provider education, and treatment options. “We are hopeful this legislation will touch on many of the stakeholder recommendations, including but not limited to those related to Medicare treatment options/coverage, improving data tracking/prescribing practices, and educating providers and beneficiaries about the risks of long-term opioid use,” the white paper states. AHA submitted its policy recommendations to the committee last month.

Headline
The AHA provided comments to the Medicare Payment Advisory Commission Oct. 2 on a discussion from the commission’s September meeting on its examination of…
Headline
The Centers for Medicare & Medicaid Services announced Sept. 25 that it will expand the Inpatient Rehabilitation Facility Review Choice Demonstration to…
Headline
The Centers for Medicare & Medicaid Services announced Sept. 28 that it projects declines in average premiums for Medicare Advantage and Part D in 2027.…
Headline
The Centers for Medicare & Medicaid Services Sept. 15 announced an expansion of its outcome-aligned payment model offering technology-supported care to…
Headline
The House Energy and Commerce Subcommittee on Health held a hearing Sept. 15 to discuss more than a dozen legislative proposals regarding Medicare provider…
Headline
The AHA Aug. 31 joined a coalition led by LeadingAge and other national healthcare organizations in submitting comments to the Centers for Medicare &…